Usage Information

Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose
Christophe Magnan, Stephan Collins, Marie-France Berthault, Nadim Kassis, Mylène Vincent, Marc Gilbert, Luc Pénicaud, Alain Ktorza, Françoise Assimacopoulos-Jeannet
Christophe Magnan, Stephan Collins, Marie-France Berthault, Nadim Kassis, Mylène Vincent, Marc Gilbert, Luc Pénicaud, Alain Ktorza, Françoise Assimacopoulos-Jeannet
View: Text | PDF
Article

Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose

Abstract

We investigated the possible involvement of the autonomic nervous system in the effect of a long-term elevation of plasma free fatty acid (FFA) concentration on glucose-induced insulin secretion (GIIS) in rats. Rats were infused with an emulsion of triglycerides (Intralipid) for 48 hours (IL rats). This resulted in a twofold increase in plasma FFA concentration. At the end of infusion, GIIS as reflected in the insulinogenic index (ΔI/ΔG) was 2.5-fold greater in IL rats compared with control saline-infused rats. The ratio of sympathetic to parasympathetic nervous activities was sharply decreased in IL rats relative to controls. GIIS was studied in the presence of increasing amounts of α- and β-adrenoreceptor agonists and antagonists. The lowest concentrations of the α2A-adrenoreceptor agonist oxymetazoline, which were ineffective in control rats, reduced GIIS in IL rats. At the dose of 0.3 pmol/kg, GIIS became similar in IL and control rats. The use of β-adrenoreceptor agonist (isoproterenol) or antagonist (propranolol) did not result in a significant alteration in GIIS in both groups. GIIS remained as high in IL vagotomized rats as in intact IL rats, indicating that changes in parasympathetic tone were of minor importance. Altogether, the data show that lipid infusion provokes β-cell hyperresponsiveness in vivo, at least in part through changes in α2-adrenergic innervation.

Authors

Christophe Magnan, Stephan Collins, Marie-France Berthault, Nadim Kassis, Mylène Vincent, Marc Gilbert, Luc Pénicaud, Alain Ktorza, Françoise Assimacopoulos-Jeannet

×

Usage data is cumulative from October 2025 through October 2026.

Usage JCI PMC
Text version 649 43
PDF 211 9
Figure 667 1
Table 109 0
Citation downloads 250 0
Totals 1,886 53
Total Views 1,939
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement